Search - tctmd.com

Displaying 201 - 220 of 780

Sort: Relevancy | Date

Presentation TCT 2021

TCT 537: Dual Impella Support (Impella CP & RP Impella) for Biventricular Cardiogenic Shock Just Hours Post-op After CABG With Significant Recovery

Presenter: Ramandeep Mand

November 04, 2021

Presentation TCT 2021

The Role of Drug Coated Balloons in Bifurcation Lesions

Presenter: Robert Byrne

November 04, 2021

Presentation TCT 2021

My Personal Approach to Bifurcation Lesions in 2021

Presenter: Antonio Colombo

November 04, 2021

Presentation TCT 2021

TCT 536: Impella 5.5 as a Bridge To Repair in a Post-Infarct Ventricular Septal Defect

Presenter: Vidang Nguyen

November 04, 2021

Presentation TCT 2021

Case 3: Planned Two Stents and Why I Chose This Two-Stent Technique

Presenter: Sahil Khera

November 04, 2021

Presentation TCT 2021

Case 2: Provisional Ending With Two Stents

Presenter: Katherine Kunkel

November 04, 2021

Presentation TCT 2021

Case 1: Provisional With One Stent – Does FFR Help Us?

Presenter: Bon-Kwon Koo

November 04, 2021

Presentation TCT 2021

Top Tips and Tricks for Bifurcation: My Top Five

Presenter: Thierry Lefevre

November 04, 2021

Presentation TCT 2021

The Most Relevant Studies Regarding Bifurcation Lesions in the Past Two Years

Presenter: Nadia Sutton

November 04, 2021

News Conference News TCT 2021

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

Caitlin E. Cox

November 04, 2021

Presentation TCT 2021

iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

Presenter: Matthias Götberg

November 04, 2021

Presentation TCT 2021

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

Presenter: Ajay Kirtane

November 04, 2021

News Conference News TCT 2021

OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III

Shelley Wood

November 04, 2021

Presentation TCT 2021

OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

Presenter: David Kandzari

November 04, 2021

News Conference News TCT 2021

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

Yael L. Maxwell

November 04, 2021

Presentation TCT 2021

Amplitude Vascular: Novel Approach to Intravascular Lithotripsy

Presenter: Hitinder S. Gurm

November 04, 2021

Presentation TCT 2021

FAVOR III China: A Sham-Controlled Randomized Trial Comparing QFR-Guided and Angiography-Guided PCI

Presenter: Bo Xu

November 04, 2021

News Conference News TCT 2021

FAVOR III China Adds Strength to Value of QFR-Guided PCI

L.A. McKeown

November 04, 2021

Presentation TCT 2021

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

Presenter: William Fearon

November 04, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

Advertisement

TCT 537: Dual Impella Support (Impella CP & RP Impella) for Biventricular Cardiogenic Shock Just Hours Post-op After CABG With Significant Recovery

The Role of Drug Coated Balloons in Bifurcation Lesions

My Personal Approach to Bifurcation Lesions in 2021

TCT 536: Impella 5.5 as a Bridge To Repair in a Post-Infarct Ventricular Septal Defect

Case 3: Planned Two Stents and Why I Chose This Two-Stent Technique

Case 2: Provisional Ending With Two Stents

Case 1: Provisional With One Stent – Does FFR Help Us?

Top Tips and Tricks for Bifurcation: My Top Five

The Most Relevant Studies Regarding Bifurcation Lesions in the Past Two Years

iFR Matches FFR Through 5 Years: iFR-SWEDEHEART

iFR-SWEDEHEART: Five-Year Outcomes of a Randomized Trial of iFR-Guided vs. FFR-Guided PCI

RADIANCE-HTN: Six-Month Outcomes of a Randomized Trial of Renal Denervation Versus a Sham Procedure for Resistant Hypertension – Impact of Treatment-Blinded Medication Titration

OCT Guidance Cuts Stent Use in STEMI Without Plaque Rupture: EROSION III

OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

Amplitude Vascular: Novel Approach to Intravascular Lithotripsy

FAVOR III China: A Sham-Controlled Randomized Trial Comparing QFR-Guided and Angiography-Guided PCI

FAVOR III China Adds Strength to Value of QFR-Guided PCI

FAME 3: A Randomized Trial of FFR-Guided Stenting Compared With CABG

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content